Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by Park Place Capital Corp

Park Place Capital Corp reduced its position in shares of Stericycle, Inc. (NASDAQ:SRCL) by 42.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 853 shares of the business services provider’s stock after selling 629 shares during the period. Park Place Capital Corp’s holdings in Stericycle were worth $45,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC increased its position in Stericycle by 170.9% during the first quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock worth $43,000 after purchasing an additional 516 shares during the last quarter. Vanguard Group Inc. boosted its stake in Stericycle by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock worth $444,509,000 after buying an additional 52,576 shares during the period. Sei Investments Co. boosted its stake in Stericycle by 35.5% during the fourth quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after buying an additional 277,896 shares during the period. Natixis Investment Managers International boosted its stake in Stericycle by 23.6% during the fourth quarter. Natixis Investment Managers International now owns 3,207 shares of the business services provider’s stock worth $159,000 after buying an additional 612 shares during the period. Finally, Thematics Asset Management boosted its stake in Stericycle by 15.1% during the fourth quarter. Thematics Asset Management now owns 492,471 shares of the business services provider’s stock worth $24,407,000 after buying an additional 64,471 shares during the period. 98.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have weighed in on SRCL shares. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 target price (down previously from $69.00) on shares of Stericycle in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods increased their target price on shares of Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. StockNews.com started coverage on shares of Stericycle in a research note on Saturday. They set a “hold” rating for the company. Robert W. Baird lowered their target price on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a research note on Friday, April 26th. Finally, Truist Financial raised their price objective on shares of Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Stericycle has a consensus rating of “Hold” and an average price target of $74.00.

Stericycle Trading Down 0.1 %

SRCL stock opened at $58.08 on Tuesday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 1.11. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $59.45. The company’s 50 day moving average is $51.92 and its two-hundred day moving average is $50.86.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The company had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same quarter last year, the company earned $0.49 earnings per share. The firm’s revenue for the quarter was down 2.8% on a year-over-year basis. As a group, equities research analysts expect that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.